GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: RP60556A is the most potent compound from the benzo[b]naphthyridones, a series of antibacterial compounds active against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) [1]. It was being developed as a topical treatment by Sanofi-Aventis but has been discontinued.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 7-fluoro-8-[4-(4-fluorophenyl)piperazin-1-yl]-1-methyl-4-oxopyrido[6,5-b]quinoline-3-carboxylic acid |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
RP60556A |
| Other databases | |
| ChEMBL Ligand | CHEMBL1183217 |
| GtoPdb PubChem SID | 405560447 |
| PubChem CID | 484065 |
| Search Google for chemical match using the InChIKey | YYHFVZLNDMSUBV-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YYHFVZLNDMSUBV |
| UniChem Compound Search for chemical match using the InChIKey | YYHFVZLNDMSUBV-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | YYHFVZLNDMSUBV-UHFFFAOYSA-N |